An immunotherapy drug called 'avelumab' has been shown to significantly improve survival in patients with the most common type of bladder cancer, according to results from a phase III clinical trial led by Queen Mary University ...
Sep 18, 2020
0
34
Researchers have created a mathematical model that can determine the impact of the immune system on tumor evolution. The information gained from using this model may be able to be used to predict whether immunotherapy is ...
Sep 15, 2020
0
70
Sophie Lucas (University of Louvain de Duve Institute) and her team have succeeded in neutralizing a molecule that blocks the immune system against cancer. The UCLouvain scientists discovered that this new immunotherapy increases ...
Sep 11, 2020
0
27
Johns Hopkins Medicine researchers have added to evidence that a gene responsible for turning off a cell's natural "suicide" signals may also be the culprit in making breast cancer and melanoma cells resistant to therapies ...
Sep 1, 2020
0
120
A team with the participation of researchers from the ICMAB has designed new hydrogels for culturing T-cells or T-lymphocytes, cells of the immune system that are used in cancer immunotherapy with the capacity to destroy ...
Aug 31, 2020
0
6
Cancer immunotherapy—empowering a patient's own immune system to clear away tumors on its own—holds great promise for some patients. But for other patients, immunotherapy just doesn't work.
Aug 17, 2020
0
121
Researchers with the Snyder Institute for Chronic Diseases at the Cumming School of Medicine (CSM) have discovered which gut bacteria help our immune system battle cancerous tumors and how they do it. The discovery may provide ...
Aug 13, 2020
0
235
A test which detects changing levels of tumor fragments in the blood may be an easy, non-invasive and quick way to predict who will benefit from immunotherapy, a treatment option for advanced cancers.
Aug 3, 2020
0
158
Researchers at the UCLA Jonsson Comprehensive Cancer Center and UCLA School of Dentistry have identified a potential new combination therapy to treat advanced head and neck squamous cell carcinoma, the most common type of ...
Jul 22, 2020
0
0
Preliminary data from researchers at the University of Cincinnati Cancer Center show that immunotherapy doesn't necessarily worsen complications for patients with both COVID-19 and cancer.
Jul 20, 2020
0
1
